BREAKING
Protagonist Therapeutics Jumps 7.0% in Broad Rally 6 hours ago Valaris Limited Drops 6.7% in Broad Selloff 7 hours ago Talos Energy Inc. Drops 6.2% Amid Sector-Wide Selling 7 hours ago Northern Oil and Gas, Inc. Drops 5.2% in Broad Selloff 7 hours ago Bank7 Corp. Tops Q1 Forecasts With $1.25 EPS, 20.2% Above Consensus 8 hours ago JetBlue Airways Corporation Surges 15.1% in Broad Rally 8 hours ago Celanese Corporation Shares Dropping 5.5% 8 hours ago Akamai Technologies, Inc. Shares Dropping 5.3% 8 hours ago Amazon.com, Inc. (AMZN) Jumps 5.2% to $232.68 8 hours ago Boot Barn Holdings, Inc. Shares Jumping 5.2% 8 hours ago Protagonist Therapeutics Jumps 7.0% in Broad Rally 6 hours ago Valaris Limited Drops 6.7% in Broad Selloff 7 hours ago Talos Energy Inc. Drops 6.2% Amid Sector-Wide Selling 7 hours ago Northern Oil and Gas, Inc. Drops 5.2% in Broad Selloff 7 hours ago Bank7 Corp. Tops Q1 Forecasts With $1.25 EPS, 20.2% Above Consensus 8 hours ago JetBlue Airways Corporation Surges 15.1% in Broad Rally 8 hours ago Celanese Corporation Shares Dropping 5.5% 8 hours ago Akamai Technologies, Inc. Shares Dropping 5.3% 8 hours ago Amazon.com, Inc. (AMZN) Jumps 5.2% to $232.68 8 hours ago Boot Barn Holdings, Inc. Shares Jumping 5.2% 8 hours ago
ADVERTISEMENT
Market News

Earnings Summary: Eastman Chemical Company (EMN) Q2 2023 results

Eastman Chemical Company (NYSE: EMN) reported lower sales and adjusted profit for the second quarter of 2023. The management provided guidance for the full fiscal year. Total sales revenue decreased to $2.32 billion in the second quarter from $2.78 billion in the corresponding period of 2022 The chemical company reported adjusted earnings of $1.99 per […]

July 31, 2023 1 min read

Eastman Chemical Company (NYSE: EMN) reported lower sales and adjusted profit for the second quarter of 2023. The management provided guidance for the full fiscal year. Total sales revenue decreased to $2.32 billion in the second quarter from $2.78 billion in the corresponding period of 2022 The chemical company reported adjusted earnings of $1.99 per […]

Eastman Chemical Company (NYSE: EMN) reported lower sales and adjusted profit for the second quarter of 2023. The management provided guidance for the full fiscal year.

  • Total sales revenue decreased to $2.32 billion in the second quarter from $2.78 billion in the corresponding period of 2022
  • The chemical company reported adjusted earnings of $1.99 per share for the three-month period, lower than the $2.83 per share profit it reported a year earlier
  • Unadjusted profit, on a per-share basis, came in at $2.27, compared to $2.03 in the prior-year quarter
  • Net cash provided by operating activities was $410 million in the second quarter, vs. $245 million last year
  • Q2 adjusted EBITDA decreased to $336 million from $469 million in the year-ago period
  • The company said it expects the auto, aviation, and other markets to modestly improve in the second half of the year
  • Eastman is looking for earnings in the range of $6.50 per share to $7.00 per share for fiscal 2023
  • It continues to expect to generate $1.4 billion of operating cash flow this year
ADVERTISEMENT